← ANALYST RATINGS · TIPRANKS

Envista Holdings (NVST): analyst forecast and price target

$22.90 −2.55% close 16.10.26 · market cap $3.6B · Healthcare · Medical - Instruments & Supplies
Price targets and ratings of

Analyst consensus

Moderate Buy

5 Buy3 Hold0 Sell

Ratings of 8 analysts in the last 3 months · top analysts only

12-month forecast

$29.62+29.4% upside

Based on 8 price targets given in the last 3 months, the average target is $29.62, the highest $34.00, the lowest $23.00. The average is +29.4% from the last price of $22.90.

$20.00$25.00$30.00Jan 26AprJulOctJan 27AprJulOctHigh$34.00Average$29.62Low$23.00
Highest target $34.00 Average target $29.62 Lowest target $23.00
AnalystFirmPrice target RatingUpsideAction Date Move vs SPY
Jeff Johnson★★★★★★★★★★#1125 · hits 51% · avg +10.4% Robert W. Baird $34.00 → $26.00−23.5% Hold +13.5% Downgrade 15.10.26on TipRanks 05:30 +2.7%next day −1.4%
Michael Cherny★★★★★★★★★★#2074 · hits 57% · avg +5.7% Leerink Partners $35.00 → $32.00−8.6% Buy +39.7% Reiterated 14.10.26on TipRanks 09:00 +1.8%next day +2.7%
Jason Bednar★★★★★★★★★★#11450 · hits 46% · avg −2.5% Piper Sandler $28.00 → $26.00−7.1% Hold +13.5% Reiterated 09.10.26on TipRanks 07:11 +0.6%next day −1.2% · 5 days +1.5%
Allen Lutz★★★★★★★★★★#598 · hits 67% · avg +12.3% Bank of America Securities $34.00 Buy +48.5% Reiterated 07.10.26on TipRanks 10:00 −0.7%next day −1.0% · 5 days 0.0%
Brandon Vazquez★★★★★★★★★★#11688 · hits 42% · avg −5.1% William Blair — Buy — Reiterated 02.10.26on TipRanks 10:06 +0.6%next day −1.2% · 5 days −3.1%
Allen Lutz★★★★★★★★★★#598 · hits 67% · avg +12.3% Bank of America Securities $34.00 Buy +48.5% Reiterated 28.09.26on TipRanks Sep 29 05:30 −0.2%next day −1.5% · 5 days −2.8%
Vik Chopra★★★★★★★★★★#6076 · hits 45% · avg +1.9% BMO Capital $29.00 → $26.00−10.3% Hold +13.5% Reiterated 28.09.26on TipRanks 07:25 −0.2%next day −1.5% · 5 days −2.8%
David Saxon★★★★★★★★★★#6662 · hits 38% · avg +0.8% Needham — Hold — Reiterated 24.09.26on TipRanks 06:35 +1.1%next day −1.0% · 5 days −3.4%
Erin Wright★★★★★★★★★★#354 · hits 64% · avg +15.1% Morgan Stanley $23.00 Hold +0.4% Reiterated 18.09.26on TipRanks Sep 20 20:55 −1.6%next day −1.2% · 5 days +1.3%
Jonathan Block★★★★★★★★★★#2320 · hits 50% · avg +5.3% Stifel Nicolaus $31.00 Buy +35.4% Reiterated 18.09.26on TipRanks 08:35 −1.6%next day −1.2% · 5 days +1.3%
Unknown Analyst Leerink Partners $35.00 Buy +52.8% Reiterated 18.09.26on TipRanks 08:35 −1.6%next day −1.2% · 5 days +1.3%
Kevin Caliendo★★★★★★★★★★#2646 · hits 56% · avg +5.6% UBS $30.00 → $27.00−10.0% Hold +17.9% Reiterated 18.09.26on TipRanks 07:35 −1.6%next day −1.2% · 5 days +1.3%
Jason Bednar★★★★★★★★★★#11450 · hits 46% · avg −2.5% Piper Sandler $28.00 Hold +22.3% Reiterated 18.09.26on TipRanks 07:08 −1.6%next day −1.2% · 5 days +1.3%
Lilia-Celine (Lily) Lozada★★★★★★★★★★#7724 · hits 75% · avg +5.0% J.P. Morgan $32.00 Buy +39.7% Upgrade 03.09.26on TipRanks 05:35 −0.3%next day −0.7% · 5 days −6.2%
Glen Santangelo★★★★★★★★★★#2956 · hits 52% · avg +4.5% Barclays $32.00 Buy +39.7% Reiterated 17.08.26on TipRanks Aug 18 05:25 −1.1%next day +1.3% · 5 days +0.1%
Daniel Grosslight★★★★★★★★★★#4007 · hits 47% · avg +3.6% Citi $32.00 Hold +39.7% Reiterated 10.08.26on TipRanks 16:30 +1.5%next day +0.4% · 5 days −2.1%
Jeff Johnson★★★★★★★★★★#1125 · hits 51% · avg +10.4% Robert W. Baird $31.00 → $34.00+9.7% Buy +48.5% Reiterated 06.08.26on TipRanks 09:30 −4.2%next day +2.2% · 5 days +1.3%
Elizabeth Anderson CFA★★★★★★★★★★#2664 · hits 55% · avg +4.4% Evercore ISI $32.00 Buy +39.7% Reiterated 06.08.26on TipRanks 08:25 −4.2%next day +2.2% · 5 days +1.3%
Steven Valiquette★★★★★★★★★★#8240 · hits 53% · avg 0.0% Mizuho Securities $27.00 → $29.00+7.4% Hold +26.6% Reiterated 06.08.26on TipRanks 07:25 −4.2%next day +2.2% · 5 days +1.3%
Unknown Analyst Wells Fargo $21.00 → $26.00+23.8% Hold +13.5% Reiterated 06.02.26on TipRanks 08:00 +15.8%next day +0.4% · 5 days +0.8%

Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst

Best analysts covering Envista Holdings

TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.

Most accurate

3 months Allen Lutz★★★★★★★★★★Bank of America Securities · #598
Hits 67%216 of 324 Average return +12.3%
1 year Allen Lutz★★★★★★★★★★Bank of America Securities · #598
Hits 67%216 of 324 Average return +12.3%
2 years Allen Lutz★★★★★★★★★★Bank of America Securities · #598
Hits 67%216 of 324 Average return +12.3%

Most profitable

3 months Jonathan Block★★★★★★★★★★Stifel Nicolaus · #2320
Hits 50%204 of 406 Average return +5.3%
1 year Allen Lutz★★★★★★★★★★Bank of America Securities · #598
Hits 67%216 of 324 Average return +12.3%
2 years Allen Lutz★★★★★★★★★★Bank of America Securities · #598
Hits 67%216 of 324 Average return +12.3%

How the average price target moved

The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 02.10.26: target $30.38 at a price of $23.16 (+31.2%); now: $29.38 at $22.90 (+28.3%).

$22.50$25.00$27.50$30.00Sep 15Oct 1Oct 15Top analysts$29.62Average target$29.38Price$22.90

PriceAverage targetTop analysts’ target

Recommendation trend · top analysts

051015114Oct 2582Nov102Dec7Jan 26152Feb122Mar93Apr71May81Jun81Jul82Aug104Sep114Oct

Strong BuyBuyHoldSell

Rating05.2606.2607.2608.2609.2610.26
Strong Buy000000
Buy78881011
Hold111244
Sell000000

Earnings and sales forecast

Next report: 04.11.26 (Q3 2026, date not confirmed)

Earnings per share

Next quarter’s EPS estimate — $0.36 (from $0.34 to $0.38). Last quarter: $0.41.

Sales

Next quarter’s sales estimate — $689M (from $684M to $701M). Last quarter: $730M.

Best top-analyst consensus in the sector · Healthcare

AXGNAxoGen
MDWDMediwound
OCULOcular Therapeutix
OVIDOvid Therapeutics
ZYMEZymeworks
About Envista Holdings
  • CEO: Paul A. Keel
  • Employees: 12,000
  • Building E, Brea, CA, 92821-6208, US
  • www.envistaco.com

Envista Holdings Corporation is an enterprise dedicated to the development and distribution of a comprehensive range of dental solutions. These offerings are crucial for the identification, therapeutic intervention, and preventative care of diverse oral health issues, specifically addressing the teeth, gingiva (gums), and their supporting bone structures. The company's principal location is in Brea, California, and it maintains a workforce comprising 12,800 full-time personnel. The firm organizes its business activities into two main divisions: "Specialty Products & Technologies" and "Equipment & Consumables." The Specialty Products & Technologies division concentrates on the creation, fabrication, and promotion of sophisticated dental implant systems, advanced prosthetic devices, and their associated digital treatment software and technological advancements. This segment also provides orthodontic remedies, including bracket systems, clear aligners, and various items for dental laboratories. Conversely, the Equipment & Consumables division is responsible for conceptualizing, producing, and bringing to market a wide array of dental apparatus and vital supplies intended for professional dental clinics. This extensive catalog includes digital imaging instruments, specialized software, and visual or magnification systems; patient treatment units and other essential fixtures for dental practices; complete endodontic kits along with their complementary consumable items; materials and tools for restorative dentistry; rotary cutting tools (burs); impression-making compounds; adhesive agents and dental cements; and products designed for infection control.

Data from the stock’s TipRanks forecast page, read 36 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗